Latest Insider Transactions at Janux Therapeutics, Inc. (JANX)
This section provides a real-time view of insider transactions for Janux Therapeutics, Inc. (JANX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Janux Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Janux Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.68%
|
$300,000
$60.0 P/Share
|
|
Jan 02
2025
|
Maria Dobek Vice President, Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+50.0%
|
-
|
|
Jan 02
2025
|
Thomas Di Raimondo Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+15.61%
|
-
|
|
Jan 02
2025
|
Byron Robinson Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+50.0%
|
-
|
|
Jan 02
2025
|
David Alan Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
81,000
+21.37%
|
-
|
|
Jan 02
2025
|
Charles M. Winter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+22.93%
|
-
|
|
Jan 02
2025
|
Zachariah Mc Iver Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,000
+50.0%
|
-
|
|
Jan 02
2025
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,334
-2.94%
|
$733,370
$55.64 P/Share
|
|
Jan 02
2025
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+15.86%
|
-
|
|
Dec 24
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-10.33%
|
$1,400,000
$56.19 P/Share
|
|
Dec 19
2024
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,881
+5.66%
|
$167,977
$17.13 P/Share
|
|
Dec 03
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
15,000
-5.84%
|
$1,005,000
$67.0 P/Share
|
|
Nov 25
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.51%
|
$1,275,000
$51.74 P/Share
|
|
Nov 05
2024
|
Sheila Gujrathi |
BUY
Other acquisition or disposition
|
Direct |
4,611
+3.85%
|
-
|
|
Nov 05
2024
|
Vickie L Capps |
BUY
Other acquisition or disposition
|
Direct |
2,305
+3.17%
|
-
|
|
Oct 28
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.16%
|
$1,325,000
$53.58 P/Share
|
|
Oct 18
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,200,000
+11.41%
|
$52,800,000
$44.75 P/Share
|
|
Oct 18
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
801,751
-8.36%
|
$38,484,048
$48.74 P/Share
|
|
Oct 18
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
660,018
-8.36%
|
$31,680,864
$48.74 P/Share
|
|
Oct 17
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
1,843
-22.44%
|
$92,150
$50.02 P/Share
|
|
Oct 17
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,769
+5.41%
|
$35,380
$20.19 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
100,610
-22.05%
|
$5,030,500
$50.37 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,515
+15.35%
|
$210,300
$20.19 P/Share
|
|
Oct 16
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
108,906
-1.6%
|
$5,445,300
$50.15 P/Share
|
|
Sep 30
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
958
-12.21%
|
$44,068
$46.24 P/Share
|
|
Sep 30
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
919
+2.94%
|
$18,380
$20.19 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
49,231
-7.51%
|
$2,264,626
$46.78 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,752
+5.03%
|
$35,040
$20.19 P/Share
|
|
Sep 27
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
57,590
-0.83%
|
$2,706,730
$47.08 P/Share
|
|
Sep 27
2024
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.55%
|
$1,150,000
$46.93 P/Share
|
|
Sep 27
2024
|
Thomas Di Raimondo Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.44%
|
$230,000
$46.72 P/Share
|
|
Sep 27
2024
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
50,000
-42.52%
|
$2,250,000
$45.96 P/Share
|
|
Sep 27
2024
|
Andrew Hollman Meyer Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+29.83%
|
$200,000
$4.21 P/Share
|
|
Sep 26
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
109,700
-1.54%
|
$5,155,900
$47.28 P/Share
|
|
Sep 26
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
90,300
-1.54%
|
$4,244,100
$47.28 P/Share
|
|
Sep 13
2024
|
Jay Lichter |
SELL
Open market or private sale
|
Direct |
3,815
-35.28%
|
$175,490
$46.68 P/Share
|
|
Sep 13
2024
|
Jay Lichter |
BUY
Exercise of conversion of derivative security
|
Direct |
3,815
+8.82%
|
$76,300
$20.19 P/Share
|
|
Sep 12
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
191,969
-5.07%
|
$9,022,543
$47.0 P/Share
|
|
Sep 12
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
158,031
-5.07%
|
$7,427,457
$47.0 P/Share
|
|
Sep 10
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
55,446
-0.72%
|
$2,550,516
$46.4 P/Share
|
|
Sep 10
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
45,645
-0.72%
|
$2,099,670
$46.4 P/Share
|
|
Sep 09
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
2,182
-23.76%
|
$91,644
$42.33 P/Share
|
|
Sep 09
2024
|
Avalon Ventures Xi, L.P. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,099
+5.74%
|
$41,980
$20.19 P/Share
|
|
Sep 06
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Indirect |
131,635
-3.31%
|
$5,528,670
$42.0 P/Share
|
|
Sep 06
2024
|
Avalon Ventures Xi, L.P. |
SELL
Open market or private sale
|
Direct |
108,365
-3.31%
|
$4,551,330
$42.0 P/Share
|
|
Jul 19
2024
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+37.5%
|
-
|
|
Jul 19
2024
|
Natasha Hernday |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+37.5%
|
-
|
|
Jun 26
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
2,500
+50.0%
|
-
|
|
Jun 26
2024
|
Vickie L Capps |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+3.54%
|
-
|
|
Jun 26
2024
|
Jake Simson |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+50.0%
|
-
|